Vyome Holdings (HIND) Retained Earnings (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Retained Earnings of -$118318.0 for Q1 2026, down 100.02% year-over-year from $642.6 million in Q1 2025, and down 100.13% quarter-over-quarter from $90.1 million in Q4 2025.
Vyome Holdings (HIND) Retained Earnings (2015 - 2026) Analysis & Trends
Vyome Holdings' Retained Earnings history runs 12 years deep, the most recent figure standing at -$118318.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 100.02% year-over-year to -$118318.0; the TTM figure through Mar 2026 stood at -$118318.0 (down 100.02% YoY), while the FY2025 annual figure was $90.1 million, up 76.33% from the prior year.
- Retained Earnings for Q1 2026 stood at -$118318.0, down from $90.1 million in the prior quarter.
- The five-year high for Retained Earnings was $642.6 million in Q1 2025, with the low at -$639.4 million in Q2 2024.
- The 5-year median for Retained Earnings is -$88000.0 (2022), against an average of -$18.0 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 219.63% in 2022, then slumped 722143.18% in 2023.
- Vyome Holdings' Retained Earnings stood at -$88000.0 in 2022, then plunged by 722143.18% to -$635.6 million in 2023, then soared by 108.04% to $51.1 million in 2024, then surged by 76.33% to $90.1 million in 2025, then sank by 100.13% to -$118318.0 in 2026.
- Business Quant data shows HIND's Retained Earnings at -$118318.0 in Q1 2026, $90.1 million in Q4 2025, and $88.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | -89.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89.21 Mn |
| Mar 31, 2026 | -118,318.00 |
| Dec 31, 2025 | 90.08 Mn |
| Sep 30, 2025 | 88.93 Mn |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 642.57 Mn |
| Dec 31, 2024 | 51.08 Mn |
| Sep 30, 2024 | 642.52 Mn |
| Jun 30, 2024 | -639.36 Mn |
| Mar 31, 2024 | 642.37 Mn |
| Dec 31, 2023 | -635.57 Mn |
| Sep 30, 2023 | 637.05 Mn |
| Jun 30, 2023 | -630.34 Mn |
| Mar 31, 2023 | -626.85 Mn |
| Dec 31, 2022 | -88,000.00 |
| Sep 30, 2022 | -607.72 Mn |
| Jun 30, 2022 | 626.38 Mn |
| Mar 31, 2022 | -586.09 Mn |
| Dec 31, 2021 | 622.40 Mn |
| Sep 30, 2021 | -540.72 Mn |